These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2351314)

  • 1. Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen.
    Scambia G; Panici PB; Baiocchi G; Battaglia F; Ferrandina G; Greggi S; Mancuso S
    Gynecol Oncol; 1990 Jun; 37(3):323-6. PubMed ID: 2351314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
    García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.
    Namer M; Lalanne C; Baulieu EE
    Cancer Res; 1980 May; 40(5):1750-2. PubMed ID: 7371003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.
    Kohail HM; Elias EG; el-Nowiem SA; Bashirelahi N; Didolkar MS; Reed WP
    Ann Surg; 1985 May; 201(5):611-7. PubMed ID: 2986565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tamoxifen on steroid hormone receptors and creatine kinase activity in human endometrial carcinoma.
    Iacobelli S; Scambia G; Atlante G; Landoni F; Sismondi P; Vecchio FM
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):105-10. PubMed ID: 3956553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
    Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
    Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens.
    Rostagno P; Caldani C; Lahlou B
    Breast Cancer Res Treat; 1996; 37(1):77-87. PubMed ID: 8750530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.
    Shen K; Yueng W; Ngan H
    Chin Med J (Engl); 1994 Sep; 107(9):648-52. PubMed ID: 7805454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma].
    Shen K; Yueng W; Ngan H
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):284-8, 317-8. PubMed ID: 7956553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of acquired antiestrogen resistance and its management in breast cancer].
    Iino Y; Maemura M; Morishita Y
    Nihon Rinsho; 1997 May; 55(5):1149-54. PubMed ID: 9155167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical investigations of steroid receptors in normal and neoplastic squamous epithelium of the uterine cervix.
    Mosny DS; Herholz J; Degen W; Bender HG
    Gynecol Oncol; 1989 Dec; 35(3):373-7. PubMed ID: 2599474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix.
    Konishi I; Fujii S; Nonogaki H; Nanbu Y; Iwai T; Mori T
    Cancer; 1991 Sep; 68(6):1340-50. PubMed ID: 1651807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma.
    Vargas Roig LM; Lotfi H; Olcese JE; Lo Castro G; Ciocca DR
    Anticancer Res; 1993; 13(6B):2457-63. PubMed ID: 7907850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.